HighTower Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,965
Closed -$266K 3799
2025
Q4
$266K Sell
9,965
-452
-4% -$10.8K ﹤0.01% 3146
2025
Q3
$222K Buy
10,417
+670
+7% +$15.8K ﹤0.01% 3281
2025
Q2
$210K Sell
9,747
-17,033
-64% -$317K ﹤0.01% 3235
2025
Q1
$445K Buy
+26,780
New +$486K ﹤0.01% 2562
2022
Q2
Sell
-44,485
Closed -$1.08M 3221
2022
Q1
$1.08M Buy
+44,485
New +$1.08M ﹤0.01% 1714
2021
Q1
Sell
-4,959
Closed -$265K 3034
2020
Q4
$265K Buy
+4,959
New +$246K ﹤0.01% 2014
2019
Q2
Sell
-29,043
Closed -$776K 2377
2019
Q1
$776K Buy
+29,043
New +$678K 0.01% 1247
2018
Q4
Sell
-9,687
Closed -$200K 2202
2018
Q3
$200K Buy
+9,687
New +$152K ﹤0.01% 1959
2018
Q2
Sell
-15,695
Closed -$349K 2234
2018
Q1
$349K Buy
15,695
+580
+4% +$16.1K ﹤0.01% 1603
2017
Q4
$456K Buy
15,115
+3,057
+25% +$97.8K ﹤0.01% 1490
2017
Q3
$456K Buy
12,058
+237
+2% +$7.71K ﹤0.01% 1483
2017
Q2
$330K Buy
11,821
+1,450
+14% +$43.2K ﹤0.01% 1568
2017
Q1
$356K Buy
10,371
+1,175
+13% +$41.5K ﹤0.01% 1469
2016
Q4
$265K Buy
9,196
+1,499
+19% +$39.7K ﹤0.01% 1537
2016
Q3
$245K Buy
7,697
+1,200
+18% +$40.7K ﹤0.01% 1550
2016
Q2
$208K Buy
6,497
+1,337
+26% +$44.7K ﹤0.01% 1477
2016
Q1
$144K Buy
+5,160
New +$113K ﹤0.01% 1865
2015
Q2
Sell
-6,236
Closed -$203K 1516
2015
Q1
$203K Buy
+6,236
New +$214K ﹤0.01% 1429

Other funds holding ACAD